Cohen syndrome

Cohen syndrome
Synonyms	Pepper syndrome, Cervenka syndrome
Pronounce
Field
Symptoms
Complications
Onset
Duration
Types
Causes
Risks
Diagnosis
Differential diagnosis
Prevention
Treatment
Medication
Prognosis
Frequency
Deaths

Cohen syndrome (also known as Pepper syndrome or Cervenka syndrome) is a very rare autosomal recessive genetic disorder with varied expression, characterised by obesity, intellectual disability, distinct craniofacial abnormalities and potential ocular dysfunction.

Genetics

This syndrome is believed to be a gene mutation in chromosome 8 at locus 8q22 gene COH1.<ref name="pmid12730828">,

 Cohen syndrome is caused by mutations in a novel gene, COH1, encoding a transmembrane protein with a presumed role in vesicle-mediated sorting and intracellular protein transport, 
 American Journal of Human Genetics, 
 
 Vol. 72(Issue: 6),
 pp. 1359–69,
 DOI: 10.1086/375454,
 PMID: 12730828,
 PMC: 1180298,</ref> It has an autosomal recessive transmission with variable expression.<ref name="pmid11477603">, 
 Cohen syndrome: essential features, natural history, and heterogeneity, 
 American Journal of Medical Genetics, 
 
 Vol. 102(Issue: 2),
 pp. 125–35,
 DOI: <125::AID-AJMG1439>3.0.CO;2-0 10.1002/1096-8628(20010801)102:2<125::AID-AJMG1439>3.0.CO;2-0,
 PMID: 11477603,</ref> There is evidence that this syndrome has a different mutation in the same gene as Mirhosseini–Holmes–Walton syndrome.<ref name="pmid3096139">, 
 Are the Mirhosseini-Holmes-Walton syndrome and the Cohen syndrome identical?, 
 American Journal of Medical Genetics, 
 
 Vol. 25(Issue: 2),
 pp. 397–8,
 DOI: 10.1002/ajmg.1320250227,
 PMID: 3096139,</ref><ref name="pmid10842298">, 
 Homozygosity mapping in a family with microcephaly, mental retardation, and short stature to a Cohen syndrome region on 8q21.3-8q22.1: redefining a clinical entity, 
 American Journal of Medical Genetics, 
 
 Vol. 92(Issue: 4),
 pp. 285–92,
 DOI: <285::aid-ajmg13>3.0.co;2-d 10.1002/(sici)1096-8628(20000605)92:4<285::aid-ajmg13>3.0.co;2-d,
 PMID: 10842298,</ref>

Diagnosis

Cohen syndrome is diagnosed by clinical examination but is often difficult due to variation in expression. Ocular complications, though rare, are listed as optic atrophy, microphthalmia, pigmentary chorioretinitis, hemeralopia (decreased vision in bright light), myopia, strabismus, nystagmus and iris/retinal coloboma.

General appearance is obesity with thin/elongated arms and legs. Micrognathia, short philtrum and high vaulted palate are common. Variable intellectual disability with occasional seizure and deafness also is characteristic of Cohen syndrome.

Management

Some of the symptoms of Cohen syndrome can be addressed through early intervention with medical specialists. Those who have this disease may benefit from early exposure to speech, physical, and occupational therapy to correct symptoms such as joint overflexibility, developmental delays, hypotonia, and motor clumsiness.<ref name=":2">

Cohen syndrome(link). {{{website}}}.

Accessed 2018-11-09.

</ref> Diagnosis may potentially be delayed due to the lack of a definitive molecular test as well as the clinical variability of published case reports.<ref>,

 Diagnostic criteria, clinical characteristics, and natural history of Cohen syndrome, 
 Journal of Medical Genetics, 
 
 Vol. 40(Issue: 4),
 pp. 233–41,
 DOI: 10.1136/jmg.40.4.233,
 PMID: 12676892,
 PMC: 1735413,</ref>

Glasses are beneficial to those who have severe nearsightedness, whereas individuals with retinal degeneration need training for the visually impaired, which is usually more beneficial when this is addressed at a young age. Younger patients start out having unimpaired vision, but it starts to deteriorate at a young age and does so slowly.<ref>,

 Cohen syndrome: essential features, natural history, and heterogeneity, 
 American Journal of Medical Genetics, 
 
 Vol. 102(Issue: 2),
 pp. 125–35,
 DOI: <125::aid-ajmg1439>3.0.co;2-0 10.1002/1096-8628(20010801)102:2<125::aid-ajmg1439>3.0.co;2-0,
 PMID: 11477603,</ref> If vision is able to improve with the use of glasses, it usually improves cognitive skills as well.<ref>

,

 Cohen Syndrome - NORD (National Organization for Rare Disorders) Full text, 
 NORD (National Organization for Rare Disorders), 
  
  
  
  
 Accessed on: 2018-11-09.

</ref>

The type of therapy needed for each individual varies, as not every affected individual would benefit from speech, physical, and occupational therapies. The type of therapy for each person is highly individualized. Individuals who have Cohen syndrome may also benefit from psychosocial support.<ref name = "Wang_1993">,

 Cohen Syndrome, 
 , 
 
 
 
 
 PMID: 20301655,
 
 
 Full text,
 Accessed on: 2018-11-10.</ref>

Many people who have Cohen syndrome also suffer from neutropenia which is a condition in which an individual has an abnormally low number of white blood cells called neutrophils. Having this condition may make these individuals susceptible to infections. Granulocyte-colony stimulating factor (G-CSF) is one possible treatment for neutropenia.<ref name = "Wang_1993" />

Monitoring weight gain and growth is crucial, as well as annual ophthalmologic and hematologic evaluations and checkups.<ref name=":2" /> While there are treatments available to people with Cohen syndrome, there are no known cures for the disease.

Prevalence

Over the past several years, there have been approximately 50 new cases worldwide. There are population groups with this condition in Australia, New Zealand, the UK and the US. It still seems to go undiagnosed, leaving the number of known cases less than 500.

Etymology

The syndrome is named after Michael Cohen, William Pepper and Jaroslav Cervenka, who researched the illness.

External links

• GeneReview/NIH/UW entry on Cohen syndrome

   This article is a medical stub. You can help WikiMD by expanding it!

• 
  Cohen syndrome